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Introduction
Cardiac resynchronization therapy (CRT) is an estab-
lished treatment for patients with advanced heart failure
(HF). However, a significant proportion of patients do
not gain benefit from CRT, the reasons for which are
unclear. Despite an established predictive role in HF,
the significance of right ventricular (RV) dysfunction in
gauging clinical benefit from CRT has not been eluci-
dated. Cardiovascular magnetic resonance (CMR) is an
important tool in the assessment of HF and is consid-
ered the gold-standard in estimating RV function. We
used this technique to assess the impact of RV dysfunc-
tion on clinical outcomes in HF patients receiving CRT.
Methods
We evaluated 48 consecutive patients attending a heart
failure pacing clinic who had a CMR study within
6 months of CRT implantation. Clinical, biochemical,
ECG and imaging data were collected. CMR parameters
included biventricular function and myocardial scar
assessed by gadolinium enhancement. The primary end-
point was a composite of death from any case or
unplanned hospitalization for a major cardiovascular
event. Patients were also evaluated for response to CRT.
This was defined as an improvement of left ventricular
ejection fraction (LVEF) >5% at 12 months after device
implantation.
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The mean age was 64.5±12.7 years. HF was ischemic in
42% of patients, and 85% were in NYHA class III/IV at
the time of implantation. Atrial fibrillation/flutter was
found in 27% of patients. The mean LVEF estimated by
CMR was 27 ± 8%, while the median RVEF was 52%
(interquartile range 35-63%). The mean tricuspid annu-
lar plane systolic excursion (TAPSE) was 14.0 ±6.0 mm,
and the mean pulmonary artery pressure (determined by
echocardiography) was 36.9 ±10.4 mmHg. Ten patients
(21%) met the primary end-point over a mean follow-up
period of 28.6 months, and 21 out of 44 patients (48%)
were considered responders to CRT. On time-to-event
analysis, only atrial fibrillation (HR 4.8, p=0.02) and RV
dysfunction, either by reduced RVEF (HR 0.96, p=0.01)
or TAPSE (HR 0.80, p<0.01) were independent predic-
tors of the primary end-point. Atrial fibrillation and low
RVEF were the only independent predictors of all-cause
mortality (log-rank p=0.03 and 0.04, respectively). Cor-
onary artery disease, as well as impaired RV function,
emerged as independent predictors of non-response
to CRT.
Conclusions
Right ventricular dysfunction is an independent predic-
tor of adverse clinical outcome as well as response to
CRT. Routine assessment of the right ventricle may be
of benefit for selecting patients for CRT implantation.
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